Salud en Mis Manos - Dissemination and Implementation Assistance for Cancer Prevention

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
The University of Texas Health Science Center at Houston, Houston, TX
Cancer Prevention+1 More
Salud en Mis Manos - Dissemination and Implementation Assistance - Behavioral
Eligibility
18+
Female
What conditions do you have?
Select

Study Summary

The proposed study will develop and test an implementation strategy called Salud en Mis Manos-Dissemination and Implementation Assistance (SEMM-DIA) which is an internet-accessible cross-platform that includes additional implementation support strategies to increase the reach, effectiveness, and implementation of an evidence-based breast and cervical cancer screening and HPV vaccination program for Latinas (SEMM).

Eligible Conditions

  • Cancer Prevention

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

11 Primary · 1 Secondary · Reporting Duration: 8-month follow up

8-month follow up
Cost effectiveness of SEMM-DIA in community and clinic practice settings
Implementation dose is described as the average dose of SEMM received by participants/delivered by LHWs (# of navigation calls).
Implementation dose is described as the average dose of SEMM received by participants/delivered by LHWs (time spent in education sessions).
Reach is measured by the proportion of women who participate in SEMM education sessions among those that are eligible in the clinic (among all eligible patients) & in the community (the number of participants that receive SEMM education).
8-month follow-up
Effectiveness (for HPV vaccination) as measured by the percentage of female patients who initiate or complete an HPV vaccination among all eligible patients.
Effectiveness (for screening) as measured by the percentage of women who complete cervical cancer screening (Pap or HPV screening test) among all eligible patients.
Effectiveness (for screening) as measured by the percentage of women who complete mammogram screening among all eligible patients.
Implementation (fidelity) as measured by the degree to which SEMM program components are implemented by LHWs as prescribed.
The level of Implementation will be assessed the extent to which SEMM has been carried out per clinic. (1)
The level of Implementation will be assessed the extent to which SEMM has been carried out per clinic. (2)
The level of Implementation will be assessed the extent to which SEMM has been carried out per clinic. (3)
The level of Implementation will be assessed the extent to which SEMM has been carried out per clinic. (4)

Trial Safety

Trial Design

2 Treatment Groups

Salud en Mis Manos - Usual Implementation Practice
1 of 2
Salud en Mis Manos - Dissemination and Implementation Assistance
1 of 2
Active Control
Experimental Treatment

2000 Total Participants · 2 Treatment Groups

Primary Treatment: Salud en Mis Manos - Dissemination and Implementation Assistance · No Placebo Group · N/A

Salud en Mis Manos - Dissemination and Implementation Assistance
Behavioral
Experimental Group · 1 Intervention: Salud en Mis Manos - Dissemination and Implementation Assistance · Intervention Types: Behavioral
Salud en Mis Manos - Usual Implementation Practice
Behavioral
ActiveComparator Group · 1 Intervention: Salud en Mis Manos- Usual Implementation Practice · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 8-month follow up
Closest Location: The University of Texas Health Science Center at Houston · Houston, TX
Photo of Houston 1Photo of Houston 2Photo of Houston 3
2008First Recorded Clinical Trial
2 TrialsResearching Cancer Prevention
190 CompletedClinical Trials

Who is running the clinical trial?

Centers for Disease Control and PreventionFED
819 Previous Clinical Trials
21,535,814 Total Patients Enrolled
The University of Texas Health Science Center, HoustonLead Sponsor
785 Previous Clinical Trials
243,543 Total Patients Enrolled
1 Trials studying Cancer Prevention
1,554 Patients Enrolled for Cancer Prevention
Maria E Fernandez, PhDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
2 Previous Clinical Trials
2,062 Total Patients Enrolled
1 Trials studying Cancer Prevention
1,554 Patients Enrolled for Cancer Prevention
Lara Savas, PhDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
1 Previous Clinical Trials
508 Total Patients Enrolled

Eligibility Criteria

Age 18+ · Female Participants · 9 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
Clinics or CHCs with LHWs serving Latina populations.
You serve low-income populations with low or no-cost screening and vaccination.
You provide comprehensive primary health care services.
You are a Latinas who self-identifies as Hispanic/Latina.
Latinas who have at least one unmet breast or cervical cancer prevention need, following the US Prevention Services Task Force Guidelines.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.